Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takamasa Hashimoto

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|August 19, 2024
Principal quantile treatment effect estimation using principal scoresKotaro Mizuma, Takamasa Hashimoto, Sho Sakui, et al.
Expert Review of Neurotherapeutics|February 11, 2011
Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled studyNaohisa Uchimura, Atsushi Ogawa, Misako Hamamura, et al.
Journal of Clinical Pharmacology|May 8, 2018
A Randomized, Single-Center, Double-Blind, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male SubjectsKumi Matsuno, Shingo Tanaka, Takamasa Hashimoto, et al.
Sleep Medicine|February 1, 2011
Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomniaMakoto Uchiyama, Misako Hamamura, Tomoaki Kuwano, et al.
Expert Opinion on Drug Safety|June 30, 2022
Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey)Tamio Teramoto, Hisao Ogawa, Hirotsugu Ueshima, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|August 19, 2024
Principal quantile treatment effect estimation using principal scoresKotaro Mizuma, Takamasa Hashimoto, Sho Sakui, et al.
Expert Review of Neurotherapeutics|February 11, 2011
Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled studyNaohisa Uchimura, Atsushi Ogawa, Misako Hamamura, et al.
Journal of Clinical Pharmacology|May 8, 2018
A Randomized, Single-Center, Double-Blind, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male SubjectsKumi Matsuno, Shingo Tanaka, Takamasa Hashimoto, et al.
Sleep Medicine|February 1, 2011
Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomniaMakoto Uchiyama, Misako Hamamura, Tomoaki Kuwano, et al.
Expert Opinion on Drug Safety|June 30, 2022
Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey)Tamio Teramoto, Hisao Ogawa, Hirotsugu Ueshima, et al.
Pageof 1